Photodynamic therapy for actinic keratoses: Procedure matters?

British Journal of Dermatology

Volumn 166, Issue 1, 2012, Pages 3-5

  Hauschild, A ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DICLOFENAC; FLUOROURACIL; IMIQUIMOD; METHYL AMINOLAEVULINATE; PHOTOSENSITIZING AGENT; PLACEBO; UNCLASSIFIED DRUG;

ACNE VULGARIS; ACTINIC KERATOSIS; CRYOTHERAPY; DRUG EFFICACY; DRUG SELECTIVITY; HUMAN; LIGHT EMITTING DIODE; NANOEMULSION; NONMELANOMA SKIN CANCER; NOTE; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; SKIN CANCER; TREATMENT RESPONSE;

AMINOLEVULINIC ACID; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; PHOTOCHEMOTHERAPY;

EID: 84555196798     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10737.x     Document Type: Note

References (13)

1. Morton CA, McKenna KE, Rhodes LE,. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-66.
2. De Berker D, McGregor JM, Hughes BR,. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30. (Pubitemid 46098882)
3. Szeimies RM, Radny P, Sebastian M, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol 2010; 163: 386-94.
4. Dirschka T, Radny P, Dominicus R, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol 2012; 166: 137-46.
5. Moloney FJ, Collins P,. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007; 157: 87-91. (Pubitemid 46934264)
6. Gholam P, Weberschock T, Denk K, et al. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology 2011; 222: 358-62.
7. Steinbauer JM, Schreml S, Babilas P, et al. Topical photodynamic therapy with porphyrin precursors-assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009; 8: 1111-18.
8. Fritsch C, Homey B, Stahl W, et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 1998; 68: 218-21. (Pubitemid 128472013)
9. Maisch T, Worlicek C, Babilas P, et al. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model. Exp Dermatol 2008; 17: 813-20
10. Maisch T, Santarelli F, Schreml S, et al. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol 2010; 19: e302-5.
11. Hauschild A, Stockfleth E, Popp G, et al. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 2009; 160: 1066-74.
12. Szeimies RM, Stockfleth E, Popp G, et al. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol 2010; 162: 410-14.
13. Morrow DI, McCarron PA, Woolfson AD, et al. Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B 2010; 101: 59-69.